sr 2640 has been researched along with leukotriene b4 in 1 studies
| Studies (sr 2640) | Trials (sr 2640) | Recent Studies (post-2010) (sr 2640) | Studies (leukotriene b4) | Trials (leukotriene b4) | Recent Studies (post-2010) (leukotriene b4) |
|---|---|---|---|---|---|
| 31 | 1 | 8 | 5,886 | 232 | 717 |
| Protein | Taxonomy | sr 2640 (IC50) | leukotriene b4 (IC50) |
|---|---|---|---|
| Leukotriene B4 receptor 1 | Homo sapiens (human) | 0.0019 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahnfelt-Rønne, I; Bouchelouche, PN; Thomsen, MK | 1 |
1 other study(ies) available for sr 2640 and leukotriene b4
| Article | Year |
|---|---|
LTD4 increases cytosolic free calcium and inositol phosphates in human neutrophils: inhibition by the novel LTD4 receptor antagonist, SR2640, and possible relation to modulation of chemotaxis.
Topics: Calcium; Chemotaxis, Leukocyte; Cytosol; Humans; Inositol Phosphates; Leukotriene Antagonists; Leukotriene B4; Neutrophils; Quinolines; SRS-A | 1990 |